A single point mutation reveals gating of the human ClC-5 Cl-/H+ antiporter

Journal of Physiology

Volumn 591, Issue 23, 2013, Pages 5879-5893

  De Stefano, Silvia ^a   Pusch, Michael ^a   Zifarelli, Giovanni ^a  

^a CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPORTER; CIC 5 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHANNEL GATING; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENDOCYTOSIS; FEMALE; IN VIVO STUDY; MOLECULAR DYNAMICS; NONHUMAN; OOCYTE; PH MEASUREMENT; PHYSIOLOGICAL PROCESS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOICHIOMETRY; TEMPERATURE SENSITIVITY;

ANIMALS; CHLORIDE CHANNELS; FEMALE; HUMANS; ION CHANNEL GATING; OOCYTES; POINT MUTATION; XENOPUS LAEVIS;

EID: 84888432895     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.260240     Document Type: Article

References (49)

1. - channels. J Gen Physiol 123, 109-119.
2. - channels. Nature 427, 803-807.
3. Accardi A & Pusch M (2003). Conformational changes in the pore of CLC-0. J Gen Physiol 122, 277-293.
4. + exchanger. J Gen Physiol 126, 563-570.
5. Alekov AK & Fahlke C (2009). Channel-like slippage modes in the human anion/proton exchanger ClC-4. J Gen Physiol 133, 485-496.
6. Bennetts B, Roberts ML, Bretag AH & Rychkov GY (2001). Temperature dependence of human muscle ClC-1 chloride channel. J Physiol 535, 83-93.
7. + of the muscle-type ClC chloride channels. J Gen Physiol 118, 23-32.
8. + antiporter protein CLC-5. J Biol Chem 286, 44134-44144.
9. Drummond GB (2009). Reporting ethical matters in The Journal of Physiology: standards and advice. J Physiol 587, 713-719.
10. Dutzler R, Campbell EB, Cadene M, Chait BT & MacKinnon R (2002). X-ray structure of a ClC chloride channel at 3.0 Å reveals the molecular basis of anion selectivity. Nature 415, 287-294.
11. Dutzler R, Campbell EB & MacKinnon R (2003). Gating the selectivity filter in ClC chloride channels. Science 300, 108-112.
12. Engh AM & Maduke M (2005). Cysteine accessibility in ClC-0 supports conservation of the ClC intracellular vestibule. J Gen Physiol 125, 601-617.
13. Estévez R, Schroeder BC, Accardi A, Jentsch TJ & Pusch M (2003). Conservation of chloride channel structure revealed by an inhibitor binding site in ClC-1. Neuron 38, 47-59.
14. Fahlke C, Rüdel R, Mitrovic N, Zhou M & George AL, Jr. (1995). An aspartic acid residue important for voltage-dependent gating of human muscle chloride channels. Neuron 15, 463-472.
15. Fahlke C, Yu HT, Beck CL, Rhodes TH & George AL, Jr. (1997). Pore-forming segments in voltage-gated chloride channels. Nature 390, 529-532.
16. Feng L, Campbell EB, Hsiung Y & MacKinnon R (2010). Structure of a eukaryotic CLC transporter defines an intermediate state in the transport cycle. Science 330, 635-641.
17. Friedrich T, Breiderhoff T & Jentsch TJ (1999). Mutational analysis demonstrates that ClC-4 and ClC-5 directly mediate plasma membrane currents. J Biol Chem 274, 896-902.
18. Günther W, Lüchow A, Cluzeaud F, Vandewalle A & Jentsch TJ (1998). ClC-5, the chloride channel mutated in Dent's disease, colocalizes with the proton pump in endocytotically active kidney cells. Proc Natl Acad Sci U S A 95, 8075-8080.
19. Günther W, Piwon N & Jentsch TJ (2003). The ClC-5 chloride channel knock-out mouse - an animal model for Dent's disease. Pflügers Arch 445, 456-462.
20. 2+ exchange current magnitudes determined from channel-like noise and charge movements of ion transport. Biophys J 71, 759-768.
21. Ishida Y, Nayak S, Mindell JA & Grabe M (2013). A model of lysosomal pH regulation. J Gen Physiol 141, 705-720.
22. Jentsch TJ (2008). CLC chloride channels and transporters: from genes to protein structure, pathology and physiology. Crit Rev Biochem Mol Biol 43, 3-36.
23. +-exchanger and requires Ostm1 for transport activity. EMBO J 30, 2140-2152.
24. Lin CW & Chen TY (2003). Probing the pore of ClC-0 by substituted cysteine accessibility method using methane thiosulfonate reagents. J Gen Physiol 122, 147-159.
25. + exchange transporter in endosomal function and Dent's disease. Front Physiol 3, 449.
26. Lloyd SE, Pearce SH, Fisher SE, Steinmeyer K, Schwappach B, Scheinman SJ, Harding B, Bolino A, Devoto M, Goodyer P, Rigden SP, Wrong O, Jentsch TJ, Craig IW & Thakker RV (1996). A common molecular basis for three inherited kidney stone diseases. Nature 379, 445-449.
27. Ludewig U, Jentsch TJ & Pusch M (1997). Inward rectification in ClC-0 chloride channels caused by mutations in several protein regions. J Gen Physiol 110, 165-171.
28. +-exchanger ClC-7/Ostm1. J Biol Chem 288, 28611-28619.
29. + exchange transporter by polyatomic anions. J Mol Biol 362, 682-690.
30. Novarino G, Weinert S, Rickheit G & Jentsch TJ (2010). Endosomal chloride-proton exchange rather than chloride conductance is crucial for renal endocytosis. Science 328, 1398-1401.
31. Orhan G, Fahlke C & Alekov AK (2011). Anion- and proton-dependent gating of ClC-4 anion/proton transporter under uncoupling conditions. Biophys J 100, 1233-1241.
32. Picollo A, Liantonio A, Didonna MP, Elia L, Camerino DC & Pusch M (2004). Molecular determinants of differential pore blocking of kidney CLC-K chloride channels. EMBO Rep 5, 584-589.
33. + exchanger. J Gen Physiol 135, 653-659.
34. Picollo A & Pusch M (2005). Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. Nature 436, 420-423.
35. - channel disruption impairs endocytosis in a mouse model for Dent's disease. Nature 408, 369-373.
36. Pusch M, Ludewig U & Jentsch TJ (1997). Temperature dependence of fast and slow gating relaxations of ClC-0 chloride channels. J Gen Physiol 109, 105-116.
37. Rychkov GY, Pusch M, Astill DS, Roberts ML, Jentsch TJ & Bretag AH (1996). Concentration and pH dependence of skeletal muscle chloride channel ClC-1. J Physiol 497, 423-435.
38. + exchanger. FASEB J 24, 3696-3705.
39. Stauber T & Jentsch TJ (2013). Chloride in vesicular trafficking and function. Annu Rev Physiol 75, 453-477.
40. Stauber T, Weinert S & Jentsch TJ (2012). Cell biology and physiology of CLC chloride channels and transporters. Compr Physiol 2, 1745-1766.
41. Steinmeyer K, Schwappach B, Bens M, Vandewalle A & Jentsch TJ (1995). Cloning and functional expression of rat CLC-5, a chloride channel related to kidney disease. J Biol Chem 270, 31172-31177.
42. Traverso S, Elia L & Pusch M (2003). Gating competence of constitutively open CLC-0 mutants revealed by the interaction with a small organic inhibitor. J Gen Physiol 122, 295-306.
43. Wang SS, Devuyst O, Courtoy PJ, Wang XT, Wang H, Wang Y, Thakker RV, Guggino S & Guggino WB (2000). Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis. Hum Mol Genet 9, 2937-2945.
44. - accumulation. Science 328, 1401-1403.
45. Zdebik AA, Zifarelli G, Bergsdorf EY, Soliani P, Scheel O, Jentsch TJ & Pusch M (2008). Determinants of anion-proton coupling in mammalian endosomal CLC proteins. J Biol Chem 283, 4219-4227.
46. + antiporter. Biophys J 102, 2060-2069.
47. Zifarelli G & Pusch M (2007). CLC chloride channels and transporters: a biophysical and physiological perspective. Rev Physiol Biochem Pharmacol 158, 23-76.
48. + antiporter by a single point mutation. EMBO J 28, 175-182.
49. Zifarelli G & Pusch M (2010). The role of protons in fast and slow gating of the Torpedo chloride channel ClC-0. Eur Biophys J 39, 869-875.